Q/C Technologies Inc (QCLS)

$2.69 -0.12 (-4.27%)
Market Cap 11.71M
Revenue (ttm) 0.00
Net Income (ttm) -11.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 138,400
Avg Vol 206,378
Day's Range N/A - N/A
Shares Out 4.17M
Stochastic %K 0%
Beta 2.16
Analysts Strong Buy
Price Target N/A

Company Profile

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabi...

Industry: Computer Hardware
Sector: Technology
Phone: 856 848 8698
Address:
1185 Avenue of the Americas, Suite 249, New York, United States
FatClock
FatClock Aug. 19 at 1:40 PM
$QCLS Have a 10k position in QCLS, you dont bet on the name of the basketball team, you bet on the best player combinations, and they have som real solid names, working on a real solid tech, in a real solid growth industry. Very assymetric risk.
0 · Reply
KKEE122
KKEE122 Aug. 19 at 1:23 PM
$QCLS That statement reveals complete ignorance about Islam. Have you ever read about it in depth, or is your information all based on bias? Discuss the topic objectively if you actually have an opinion, instead of empty insults
0 · Reply
NiceW2Kid
NiceW2Kid Aug. 19 at 12:49 PM
$QCLS better than 50/50. Way too much going on for this to end up being a scam. Full staff, veteran chips man, location near OpenAI, lab, recent Form 3 filed by an insider. Ignore the one bear with a thousand alt accounts we have here; he's a low-IQ Muslim pedophile.
0 · Reply
Rascal7777777
Rascal7777777 Aug. 19 at 7:36 AM
$QCLS another scam.
0 · Reply
jshmon
jshmon Aug. 19 at 4:44 AM
$QCLS bought a small stake. if i get grifted by shkreli, i lose 100%. if he pulls it off, i 100x. i think its 50/50 odds lol
0 · Reply
NiceW2Kid
NiceW2Kid Aug. 19 at 1:45 AM
$QCLS bolted on about 7% additional volume after-hours
0 · Reply
TheBeautifulGopher
TheBeautifulGopher Aug. 18 at 8:11 PM
$QCLS did martin abandon this?
2 · Reply
sleepystocks123
sleepystocks123 Aug. 18 at 8:02 PM
$QCLS ahahah closed 2.69 at daily lows!! You POOR fucking loser. Major emphasis on POOR @NiceW2Kid @PostQCLSpaidlendinginfo
0 · Reply
Jj1369
Jj1369 Aug. 18 at 7:41 PM
$QCLS DOOMSDAY IS COMING THIS IS SO FUCKED ITS CRAZY MOST BEARISH SCAM ON THE MARKET
0 · Reply
ChefCurryStocks
ChefCurryStocks Aug. 18 at 5:21 PM
$QCLS lower daily lows this stock won’t see $3.00 until the next reverse split lol
0 · Reply
Latest News on QCLS
Q/C Technologies Quarterly report: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 7 days ago

Q/C Technologies Quarterly report: Q2 2026

Q/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) Development

Aug 4, 2026, 9:15 AM EDT - 15 days ago

Q/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) Development

Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative

Jul 1, 2026, 9:44 AM EDT - 7 weeks ago

Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative

Q/C Technologies Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 3 months ago

Q/C Technologies Quarterly report: Q1 2026

Q/C Technologies Annual report: Q4 2025

Apr 15, 2026, 7:00 AM EDT - 4 months ago

Q/C Technologies Annual report: Q4 2025

Q/C Technologies launches optical processing unit initiative

2026-03-18T13:20:54.000Z - 5 months ago

Q/C Technologies launches optical processing unit initiative

Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

Mar 18, 2026, 9:15 AM EDT - 5 months ago

Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

Q/C Technologies files $100M mixed securities shelf

2026-02-11T22:20:14.000Z - 6 months ago

Q/C Technologies files $100M mixed securities shelf

Q/C Technologies Registration statement: Registration Filing

Feb 11, 2026, 7:00 AM EST - 6 months ago

Q/C Technologies Registration statement: Registration Filing

Q/C Technologies appoints Voss to Board of Directors

2026-01-20T14:25:11.000Z - 7 months ago

Q/C Technologies appoints Voss to Board of Directors

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

Jan 20, 2026, 9:15 AM EST - 7 months ago

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

Q/C Technologies Inc trading resumes

2025-12-09T14:40:42.000Z - 9 months ago

Q/C Technologies Inc trading resumes

Q/C Technologies Inc trading halted, volatility trading pause

2025-12-09T14:35:17.000Z - 9 months ago

Q/C Technologies Inc trading halted, volatility trading pause

Q/C Technologies appoints Martin Shkreli as senior advisor

2025-12-09T14:20:44.000Z - 9 months ago

Q/C Technologies appoints Martin Shkreli as senior advisor

Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

Dec 9, 2025, 9:15 AM EST - 9 months ago

Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Dec 4, 2025, 12:05 PM EST - 9 months ago

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Q/C Technologies Quarterly report: Q3 2025

Nov 19, 2025, 7:00 AM EST - 9 months ago

Q/C Technologies Quarterly report: Q3 2025

Q/C Technologies enters collaboration with LightSolver

2025-10-30T13:27:23.000Z - 10 months ago

Q/C Technologies enters collaboration with LightSolver

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Oct 30, 2025, 9:15 AM EDT - 10 months ago

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Q/C Technologies Proxy statement: Proxy Filing

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies appoints Steven Frankel as senior quantum advisor

2025-10-16T13:25:30.000Z - 10 months ago

Q/C Technologies appoints Steven Frankel as senior quantum advisor

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Oct 16, 2025, 9:15 AM EDT - 10 months ago

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Q/C Technologies Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies files to sell 6.51M shares of common stock for holders

2025-10-03T21:35:06.000Z - 11 months ago

Q/C Technologies files to sell 6.51M shares of common stock for holders

Q/C Technologies Registration statement: Registration Filing

Oct 3, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Registration statement: Registration Filing

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 25, 2025, 9:15 AM EDT - 11 months ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 24, 2025, 9:15 AM EDT - 11 months ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 17, 2025, 9:24 AM EDT - 1 year ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 4, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Sep 2, 2025, 9:20 AM EDT - 1 year ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Sep 2, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 28, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Aug 19, 2025, 5:20 PM EDT - 1 year ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Q/C Technologies Quarterly report: Q2 2025

Aug 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q2 2025

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Jun 24, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Q/C Technologies Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies Quarterly report: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q1 2025

Q/C Technologies Proxy statement: Proxy Filing

May 9, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

May 8, 2025, 9:20 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 22, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Q/C Technologies Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Apr 16, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Q/C Technologies Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies Annual report: Q4 2024

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Annual report: Q4 2024

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 17, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Mar 5, 2025, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Feb 25, 2025, 9:20 AM EST - 1 year ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 29, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Jan 15, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 19, 2024, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Dec 9, 2024, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Q/C Technologies Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Q/C Technologies Quarterly report: Q3 2024

Q/C Technologies Proxy statement: Proxy Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Oct 2, 2024, 9:10 AM EDT - 2 years ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

Aug 21, 2024, 9:00 AM EDT - 2 years ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

FatClock
FatClock Aug. 19 at 1:40 PM
$QCLS Have a 10k position in QCLS, you dont bet on the name of the basketball team, you bet on the best player combinations, and they have som real solid names, working on a real solid tech, in a real solid growth industry. Very assymetric risk.
0 · Reply
KKEE122
KKEE122 Aug. 19 at 1:23 PM
$QCLS That statement reveals complete ignorance about Islam. Have you ever read about it in depth, or is your information all based on bias? Discuss the topic objectively if you actually have an opinion, instead of empty insults
0 · Reply
NiceW2Kid
NiceW2Kid Aug. 19 at 12:49 PM
$QCLS better than 50/50. Way too much going on for this to end up being a scam. Full staff, veteran chips man, location near OpenAI, lab, recent Form 3 filed by an insider. Ignore the one bear with a thousand alt accounts we have here; he's a low-IQ Muslim pedophile.
0 · Reply
Rascal7777777
Rascal7777777 Aug. 19 at 7:36 AM
$QCLS another scam.
0 · Reply
jshmon
jshmon Aug. 19 at 4:44 AM
$QCLS bought a small stake. if i get grifted by shkreli, i lose 100%. if he pulls it off, i 100x. i think its 50/50 odds lol
0 · Reply
NiceW2Kid
NiceW2Kid Aug. 19 at 1:45 AM
$QCLS bolted on about 7% additional volume after-hours
0 · Reply
TheBeautifulGopher
TheBeautifulGopher Aug. 18 at 8:11 PM
$QCLS did martin abandon this?
2 · Reply
sleepystocks123
sleepystocks123 Aug. 18 at 8:02 PM
$QCLS ahahah closed 2.69 at daily lows!! You POOR fucking loser. Major emphasis on POOR @NiceW2Kid @PostQCLSpaidlendinginfo
0 · Reply
Jj1369
Jj1369 Aug. 18 at 7:41 PM
$QCLS DOOMSDAY IS COMING THIS IS SO FUCKED ITS CRAZY MOST BEARISH SCAM ON THE MARKET
0 · Reply
ChefCurryStocks
ChefCurryStocks Aug. 18 at 5:21 PM
$QCLS lower daily lows this stock won’t see $3.00 until the next reverse split lol
0 · Reply
sleepystocks123
sleepystocks123 Aug. 18 at 5:20 PM
$QCLS if you are so confident in the stock, why aren’t you averaging down? I gotta imagine your avg is $5.00+ Gotta feel terrible to be down 50% on a stock that has zero catalysts and no support.
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Aug. 18 at 5:01 PM
$QCLS set a stop, go to bed feeling smug, wake up to your account being completely annihilated LOL. "But this stock doesn't move outside regular hours" LOLOLOL
1 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Aug. 18 at 4:49 PM
$QCLS I've been so busy laughing at the bear all morning and proving him wrong that I failed to mention 'bro has stepped away from his biotech guessing-game streaming today to participate on a conference call re: tech and the future of the company. I'm so proud and would like to think my constant browbeating and teasing had something to do with it :)
0 · Reply
Kymoneythree
Kymoneythree Aug. 18 at 4:46 PM
$QCLS down 70% since their pivot to “AI quantum company” lol The level of scam here is unmatched. So glad all these cucks below are losing their ass
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Aug. 18 at 4:06 PM
$QCLS it's buy now or pay more later I'd kill for this price entry
0 · Reply
Jj1369
Jj1369 Aug. 18 at 4:02 PM
$QCLS lower lows again today… not looking good
0 · Reply
ShangVXO
ShangVXO Aug. 18 at 3:29 PM
$QCLS ngl i’m starting to want a piece
1 · Reply
Kymoneythree
Kymoneythree Aug. 18 at 3:07 PM
$QCLS hahahah he’s the dumbest mother fucker alive! The form 3 literally shows he doesn’t have a position 😂😂😂 No wonder this guy has lost his ass… he’s a fucking retard
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Aug. 18 at 12:24 PM
$QCLS @Kymoneythree you can go ahead and close your short now, scooter; not too many insiders scoop up a big chunk of the company right before they grenade it. You've had your fun and got lucky ignoring incoming catalysts and blindly worshipping a long chart. Should have closed up shop in the 2.5's. Nothing but loss and cost to borrow interest in your future from here on out.
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Aug. 18 at 1:41 AM
$QCLS Form 3 just filed by company's CFO
0 · Reply
USAEquityResearch
USAEquityResearch Aug. 17 at 11:11 PM
$QCLS 📊 USAEquityResearch ▲ 2.81 (+1.44%) Trend: Bearish 📉 RSI (14): 49.0 — neutral territory MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 3.41 Support: 2.51 20-MA: 2.93 | 50-MA: 3.41 Educational content only. Not financial advice.
0 · Reply
sleepystocks123
sleepystocks123 Aug. 17 at 8:43 PM
$QCLS
0 · Reply